STEPHANIE WILSON: Open Payments
NPI 1144748716 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$561 in 33 payments from 17 companies in 2025. Trend: 2023 $541 · 2024 $758 · 2025 $561
Food & beverage: $561
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $204 |
| Tris Pharma Inc | 3 | $64 |
| Vanda Pharmaceuticals Inc. | 1 | $37 |
| Neuronetics, Inc. | 1 | $30 |
| Globus Medical, Inc. | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| SHIELD THERAPEUTICS INC | 1 | $23 |
| Corcept Therapeutics | 1 | $20 |
| Dexcom, Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $17 |
Products named: VRAYLAR, QULIPTA, Dyanavel XR, FANAPT, NEUROSTAR TMS THERAPY SYSTEM, UBRELVY, Senza, Auvelity.
Industry payments across UT — which companies pay providers there.
